- Record: found
- Abstract: found
- Article: not found
Colistin susceptibility test evaluation of multiple-resistance-level Pseudomonas aeruginosa isolates generated in a morbidostat device.
Mumina Javed
1
,
2 ,
Viola Ueltzhoeffer
1 ,
Maximilian Heinrich
1
,
2 ,
Hans Justus Siegrist
1 ,
Ronja Wildermuth
1 ,
Freia-Raphaella Lorenz
1 ,
Richard A Neher
3 ,
Matthias Willmann
1
,
2
December 01 2018
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Colistin is a last-resort antibiotic against the critical-status pathogen Pseudomonas aeruginosa. There is still uncertainty regarding how to accurately measure colistin susceptibility in P. aeruginosa. Evaluation of antimicrobial susceptibility testing (AST) methods is largely hampered by the lack of resistant isolates and those around the susceptibility breakpoint. The aim of this study was to generate such strains in a morbidostat device for use in AST method evaluation.